Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, … Read more
Kenvue Inc. (KVUE) - Net Assets
Latest net assets as of September 2025: $10.63 Billion USD
Based on the latest financial reports, Kenvue Inc. (KVUE) has net assets worth $10.63 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($27.25 Billion) and total liabilities ($16.61 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.63 Billion |
| % of Total Assets | 39.03% |
| Annual Growth Rate | -14.81% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 20.32 |
Kenvue Inc. - Net Assets Trend (2020–2024)
This chart illustrates how Kenvue Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Kenvue Inc. (2020–2024)
The table below shows the annual net assets of Kenvue Inc. from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $9.67 Billion | -13.76% |
| 2023-12-31 | $11.21 Billion | -43.86% |
| 2022-12-31 | $19.97 Billion | -2.10% |
| 2021-12-31 | $20.40 Billion | +11.13% |
| 2020-12-31 | $18.36 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Kenvue Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9300000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $19.00 Million | 0.20% |
| Other Comprehensive Income | $-6.15 Billion | -63.57% |
| Other Components | $15.89 Billion | 164.34% |
| Total Equity | $9.67 Billion | 100.00% |
Kenvue Inc. Competitors by Market Cap
The table below lists competitors of Kenvue Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
E.ON SE
PINK:ENAKF
|
$32.29 Billion |
|
Fujitsu Limited
PINK:FJTSF
|
$32.31 Billion |
|
Block, Inc
NYSE:XYZ
|
$32.38 Billion |
|
Arch Capital Group Ltd
NASDAQ:ACGL
|
$32.40 Billion |
|
ASM INTL N.V. NY/1 EO-04
F:AVSN
|
$32.24 Billion |
|
ASE Industrial Holding Co Ltd
TW:3711
|
$32.21 Billion |
|
Carnival Corporation
NYSE:CCL
|
$32.20 Billion |
|
EMCOR Group Inc
NYSE:EME
|
$32.16 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kenvue Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 11,211,000,000 to 9,668,000,000, a change of -1,543,000,000 (-13.8%).
- Net income of 1,030,000,000 contributed positively to equity growth.
- Dividend payments of 1,552,000,000 reduced retained earnings.
- Share repurchases of 235,000,000 reduced equity.
- Other comprehensive income decreased equity by 769,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.03 Billion | +10.65% |
| Dividends Paid | $1.55 Billion | -16.05% |
| Share Repurchases | $235.00 Million | -2.43% |
| Other Comprehensive Income | $-769.00 Million | -7.95% |
| Other Changes | $-17.00 Million | -0.18% |
| Total Change | $- | -13.76% |
Book Value vs Market Value Analysis
This analysis compares Kenvue Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.53x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.83x to 3.53x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $9.72 | $17.77 | x |
| 2021-12-31 | $10.80 | $17.77 | x |
| 2022-12-31 | $10.43 | $17.77 | x |
| 2023-12-31 | $5.85 | $17.77 | x |
| 2024-12-31 | $5.03 | $17.77 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kenvue Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.65%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.66%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 2.65x
- Recent ROE (10.65%) is above the historical average (8.25%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -4.79% | -6.08% | 0.50x | 1.59x | $-2.71 Billion |
| 2021 | 10.19% | 13.80% | 0.54x | 1.37x | $38.10 Million |
| 2022 | 10.34% | 13.81% | 0.55x | 1.37x | $67.00 Million |
| 2023 | 14.84% | 10.77% | 0.55x | 2.48x | $542.90 Million |
| 2024 | 10.65% | 6.66% | 0.60x | 2.65x | $63.20 Million |
Industry Comparison
This section compares Kenvue Inc.'s net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kenvue Inc. (KVUE) | $10.63 Billion | -4.79% | 1.56x | $32.24 Billion |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |